ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $95,665,000 | -89.8% | 13,455 | -87.8% | 0.00% | -100.0% |
| Q4 2018 | $940,775,000 | -81.8% | 110,161 | -57.4% | 0.00% | -75.0% |
| Q3 2018 | $5,171,025,000 | -3.7% | 258,293 | +24.2% | 0.00% | 0.0% |
| Q2 2018 | $5,371,968,000 | +19.9% | 207,974 | +10.9% | 0.00% | 0.0% |
| Q1 2018 | $4,480,748,000 | -32.9% | 187,479 | -4.9% | 0.00% | -33.3% |
| Q4 2017 | $6,679,651,000 | +2578915.8% | 197,098 | +1051.9% | 0.01% | – |
| Q2 2016 | $259,000 | -38.8% | 17,110 | -41.6% | 0.00% | – |
| Q1 2016 | $423,000 | -7.6% | 29,281 | +81.1% | 0.00% | -100.0% |
| Q4 2015 | $458,000 | +31.2% | 16,166 | -22.4% | 0.00% | – |
| Q3 2015 | $349,000 | -40.5% | 20,840 | -6.9% | 0.00% | -100.0% |
| Q2 2015 | $587,000 | – | 22,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
| GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
| Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
| Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
| WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
| EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
| Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
| TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
| PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |